Chief Executive Officer
Anders has a broad financial and entrepreneurial background and has successfully been structuring and developing new ventures in various branches. He also has experience from leading positions as CEO, CFO and board member in both private and listed companies.
Anders joined Isofol in 2010.
Position: Chief Executive Officer
Holdings*: 115 932 shares, 176 300 warrants**
*Own or related natural or legal person holding shares and other financial instruments in the company. Holdings as of June 30, 2019.
** Isofol Medical AB (publ) warrent program 2018 series 2018/2022 and 2018/2023 . For more information and terms read more under Corporate Governance.